Click on a filter below to refine your search. Remove a filter to broaden your search.
Did you mean: eformes
Pfizer must pay $142 million for the marketing and prescribing of epilepsy drug Neurontin for unapproved uses, a federal appeals court has ruled. The justices refused to overturn a jury’s previous...